Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor

Biochemical Journal - United Kingdom
doi 10.1042/0264-6021:3570859
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

PLoS ONE
Multidisciplinary
2014English

P Glycoprotein (ABCB1; MDR1; P-Gp)

Science-Business eXchange
2009English

P‐Glycoprotein, Multidrug Resistance and Protein Kinase C

Oncologist
Cancer ResearchMedicineOncology
1996English

P Glycoprotein (MDR1; ABCB1; P-Gp; CD243)

Science-Business eXchange
2012English

HIV-1 Integrase Inhibitors Are Substrates for the Multidrug Transporter MDR1-P-glycoprotein

Retrovirology
VirologyInfectious Diseases
2007English

Synergistic Effects of Verapamil and Anti-Mdr1 Ribozyme on Reversion of Multidrug Resistance in the P-Glycoprotein-Positive K562 Cell Line

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Characterization of Functional Assays of Multidrug Resistance P-Glycoprotein Transport Activity

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Platelet Activating Factor Revisited

Thorax
PulmonaryRespiratory Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy